Osmetech Plc
12 St. James's Square
London
SW1Y 4RB
United Kingdom
Tel: 44-20-7849-6027
Fax: 44-20-7849-6300
Website: http://www.osmetech.plc.uk/
23 articles about Osmetech Plc
-
Osmetech Plc Receives 510(k) Clearance for the eSensor(R) Thrombophilia Risk Test
4/26/2010
-
FDA Clears Osmetech Plc's Cystic Fibrosis Genotyping Test
7/9/2009
-
Osmetech Plc Board Sets its Sights on the Future
7/1/2009
-
Osmetech Plc's Exclusive Warfarin CYP4F2 Biomarker Included in Leading Warfarindosing.org Algorithm
6/8/2009
-
Osmetech Plc's eSensor XT-8 platform wins Medical Design Excellence Award
5/14/2009
-
Osmetech Plc Chosen as Principal Supplier for a Major Clinical Trial
5/13/2009
-
Osmetech Plc and Fisher HealthCare Sign U.S. Distribution Agreement
4/2/2009
-
Osmetech Plc Withdraws $44 Million IPO
12/5/2008
-
Osmetech Plc Clinical Trials Commence for Extended Warfarin Sensitivity Test
11/10/2008
-
Osmetech Plc Announces CYP450 2C9 Test Launch
11/4/2008
-
Osmetech Plc Release: Warfarin Sensitivity Study Results Update on Proposed Issue of American Depositary Shares, Osmetech Plc Study
10/31/2008
-
Osmetech Plc and QIAGEN Sign Development and Supply Agreement for QIAplex-Based Respiratory Viral Molecular Test
9/22/2008
-
Osmetech Plc Announces Initial Public Offering of American Depositary Shares
9/12/2008
-
Osmetech Plc Announces Board changes
8/12/2008
-
Osmetech Plc Announces First Shipments of New eSensorĀ® XT-8 Platform and Warfarin Sensitivity Test
7/31/2008
-
FDA Clears Osmetech Plc's Warfarin Sensitivity Test and New eSensor(R) XT-8 Platform
7/22/2008
-
Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism
2/22/2008
-
Osmetech Plc: Warfarin Test Submitted For FDA Approval
1/7/2008
-
Osmetech Plc: Commencement of Clinical Trials for Warfarin
11/12/2007
-
Osmetech Plc Licenses Warfarin Biomarker from Marshfield Clinic
11/2/2007